Tissue-based gene expression profiling can detect disease before it is visible from histology, more precisely capture disease activity, stage, and degree of injury, and has been shown to improve histology-based diagnosis of antibody-mediated rejection (AMR) and T-cell mediated rejection (TCMR) in kidney allografts.(1–3)
No takes yet. Share an insight, caveat, or question.
Giarraputo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: